Massachusetts Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
15,720
+325
| +2% | +$21.3K | 0.58% | 66 |
|
|
2025
Q1 | $1.09M | Buy |
15,395
+935
| +6% | +$66K | 0.74% | 57 |
|
|
2024
Q4 | $950K | Sell |
14,460
-90
| -0.6% | -$5.92K | 0.59% | 68 |
|
|
2024
Q3 | $1.03M | Sell |
14,550
-285
| -2% | -$20.1K | 0.65% | 63 |
|
|
2024
Q2 | $984K | Hold |
14,835
| – | – | 0.66% | 59 |
|
|
2024
Q1 | $1.01M | Sell |
14,835
-150
| -1% | -$10.2K | 0.71% | 56 |
|
|
2023
Q4 | $926K | Sell |
14,985
-90
| -0.6% | -$5.56K | 0.75% | 54 |
|
|
2023
Q3 | $889K | Sell |
15,075
-750
| -5% | -$44.2K | 0.82% | 51 |
|
|
2023
Q2 | $945K | Buy |
15,825
+750
| +5% | +$44.8K | 0.9% | 48 |
|
|
2023
Q1 | $881K | Sell |
15,075
-915
| -6% | -$53.5K | 0.91% | 47 |
|
|
2022
Q4 | $989K | Buy |
+15,990
| New | +$989K | 0.96% | 47 |
|